Evidence map›Paper›PMID 30190480›Full record

ArticleTranslational psychiatry2018

DISC1 regulates N-methyl-D-aspartate receptor dynamics: abnormalities induced by a Disc1 mutation modelling a translocation linked to major mental illness.

Elise L V Malavasi, Kyriakos D Economides, Ellen Grünewald, Paraskevi Makedonopoulou, Philippe Gautier, Shaun Mackie, Laura C Murphy, Hannah Murdoch, Darragh Crummie, Fumiaki Ogawa and 26 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Protein quality control ofFrontiers in cellular neuroscience · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Frontiers in cellular neuroscience · 2020
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 9 institutions in 4 countries.

Elise L V MalavasiCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Kyriakos D EconomidesXtuit Pharmaceuticals, Waltham, MA, USA.
Ellen GrünewaldCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Paraskevi MakedonopoulouCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Philippe GautierMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Shaun MackieCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Laura C MurphyCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Hannah MurdochMolecular Pharmacology Group, Wolfson Building, Institute of Neuroscience and Psychology, The University of Glasgow, University Avenue, Glasgow, UK.
Darragh CrummieCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Fumiaki OgawaCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Daniel L McCartneyCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Shane T O'SullivanCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Karen BurrCentre for Regenerative Medicine, The University of Edinburgh, Edinburgh, UK.
Helen S TorranceCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Jonathan PhillipsCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Marion BonneauCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Susan M AndersonCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Paul PerryMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Matthew PearsonMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Costas ConstantinidesCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Hazel Davidson-SmithCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Mostafa KabiriTranslational In Vivo Models at Sanofi, Frankfurt, Germany.
Barbara DuffDivision of Psychiatry, The University of Edinburgh, Edinburgh, UK.
Mandy JohnstoneCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-8398-0862
H Greg PolitesRegeneron Pharmaceuticals, Tarrytown NY, USA.
Stephen M LawrieDivision of Psychiatry, The University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-2444-5675
Douglas H BlackwoodDivision of Psychiatry, The University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-4076-9346
Colin A SempleMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Kathryn L EvansCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
Michel DidierTranslational Sciences at Sanofi, Chilly-Mazarin, France.
Siddharthan ChandranCentre for Regenerative Medicine, The University of Edinburgh, Edinburgh, UK.
Andrew M McIntoshDivision of Psychiatry, The University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-0198-4588
David J PriceCentre for Integrative Physiology, The University of Edinburgh, Edinburgh, UK.
Miles D HouslaySchool of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
David J PorteousCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-1249-6106
J Kirsty MillarCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK. kirsty.millar@igmm.ed.ac.uk.
Institute of Genetics and Cancer · GBUniversity of Edinburgh · GBMRC Centre for Regenerative Medicine · GBAMAG Pharmaceuticals (United States) · USKing's College London · GBRegeneron (United States) · USSanofi (France) · FRSanofi (Germany) · DEUniversity of Glasgow · GB

Funding

Chief Scientist Office SCD/12Medical Research Council G0902166Medical Research Council MC_UU_00007/16Medical Research Council MR/J0043567/1Medical Research Council MR/J004367/1Medical Research Council MR/K026992/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/C011202/1Wellcome Trust 100135Wellcome Trust WT/100135/Z/12/Z
6 · The paper itself

Abstract

The neuromodulatory gene DISC1 is disrupted by a t(1;11) translocation that is highly penetrant for schizophrenia and affective disorders, but how this translocation affects DISC1 function is incompletely understood. N-methyl-D-aspartate receptors (NMDAR) play a central role in synaptic plasticity and cognition, and are implicated in the pathophysiology of schizophrenia through genetic and functional studies. We show that the NMDAR subunit GluN2B complexes with DISC1-associated trafficking factor TRAK1, while DISC1 interacts with the GluN1 subunit and regulates dendritic NMDAR motility in cultured mouse neurons. Moreover, in the first mutant mouse that models DISC1 disruption by the translocation, the pool of NMDAR transport vesicles and surface/synaptic NMDAR expression are increased. Since NMDAR cell surface/synaptic expression is tightly regulated to ensure correct function, these changes in the mutant mouse are likely to affect NMDAR signalling and synaptic plasticity. Consistent with these observations, RNASeq analysis of the translocation carrier-derived human neurons indicates abnormalities of excitatory synapses and vesicle dynamics. RNASeq analysis of the human neurons also identifies many differentially expressed genes previously highlighted as putative schizophrenia and/or depression risk factors through large-scale genome-wide association and copy number variant studies, indicating that the translocation triggers common disease pathways that are shared with unrelated psychiatric patients. Altogether, our findings suggest that translocation-induced disease mechanisms are likely to be relevant to mental illness in general, and that such disease mechanisms include altered NMDAR dynamics and excitatory synapse function. This could contribute to the cognitive disorders displayed by translocation carriers.

Indexed as

Translocation, GeneticAdaptor Proteins, Vesicular TransportAnimalsCarrier ProteinsGenome-Wide Association StudyHumansMiceModels, AnimalMood DisordersMutationNerve Tissue ProteinsNeuronal PlasticityNeuronsReceptors, N-Methyl-D-AspartateSchizophreniaSequence Analysis, RNAAdaptor Proteins, Vesicular TransportCarrier ProteinsDisc1 protein, mouseGprin1 protein, mouseNerve Tissue ProteinsNR2B NMDA receptorReceptors, N-Methyl-D-AspartateTrak1 protein, mouse

Identifiers

PMID30190480
PMCPMC6127284
OpenAlexW2808155856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.